Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison

Table 3 Patient characteristics for the additional matching-adjusted indirect comparison analysis

		Fexuprazan 10 mg BID[3], before matching (n = 102)	Fexuprazan 10 mg BID[3], after matching (n = 87.51)	Rebamipide 100 mg TID[16] (n = 99)
Age, years		46.4	49.8	49.8
Male		35.3	36.4	36.4
Erosion	2 (1-2 erosions)	56.9	45.5	45.5
	3 (3-5 erosions)	24.5	23.2	23.2
	4 (≥ 6 erosions)	18.6	31.3	31.3

¹Effective sample size was computed as the square of the summed weights divided by the sum of the squared weights.

Data are expressed as percentages of patients, unless specified otherwise. Matching variables included in the scenario are indicated in bold.